Sebi’s valuation framework bars use of own trades.
The new FPI regulations would come into force with immediate effect, the Sebi said in a notification issued on Monday.
The selected company will be responsible for designing, implementing and supporting a big data solution with analytical capabilities.
The probe found that the promoter entities traded in the scrip with prior price sensitive information.
The company in an emailed statement said: "There has been no transaction of purchase of shares".
The proposed move assumes significance in the wake of several auditors in the recent past decided to exit from their audit mandate.
SAT partly allowed disgorgement of the Rs 13 crore fee from the auditor.
Sun Pharma, however, did not provide any specific details on the reasons for the SEBI to order the forensic audit.
The limit for FPI investment in debt was revised from Rs 6.49 lakh cr to over Rs 6.98 lakh cr for the April 2019-Sept 2019.
The shares of Mid-Cap and Small-Cap companies have seen huge price erosion in recent times.